How can healthcare companies successfully navigate innovation, regulation, and market entry in a data-driven era?
In this episode of Decisions Now, host Erin Pearson speaks with Aleksandar Ruzicic about how value-based healthcare, patient-centric design, and data science are reshaping commercial strategies in life sciences.
Alex shares powerful real-world examples from rare diseases, obesity treatments, and global market launches, revealing how integrating value metrics into R&D, regulatory planning, and go-to-market execution leads to smarter decisions and sustainable growth.
Listen to Decisions Now wherever you get your podcasts. We’re on Spotify, Apple Podcasts, and Amazon Music.
